Cargando…
Efficacy and Safety of Chemotherapy in Elderly Patients with Unresectable Pancreatic Cancer
Background/Aims: The incidence of pancreatic cancer (PC) is gradually increasing among elderly individuals, but there are insufficient clinical data on elderly individuals. To determine the efficacy and safety of chemotherapy, we compared the. the outcomes of elderly patients with unresectable PC. M...
Autores principales: | Kwan, Byung Soo, Lee, Ok Jae, Kim, Hyun Jin, Kim, Kwang Min, Shim, Sang Goon, Cho, Dae Hyeon, Kong, Sung Min, Kim, Jun Young, Ji, Jun Ho |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10178943/ https://www.ncbi.nlm.nih.gov/pubmed/37176774 http://dx.doi.org/10.3390/jcm12093334 |
Ejemplares similares
-
FOLFIRINOX in borderline resectable and locally advanced unresectable
pancreatic adenocarcinoma
por: Yoo, Changhoon, et al.
Publicado: (2020) -
Clinical Outcomes of Conversion Surgery after Neoadjuvant Chemotherapy in Patients with Borderline Resectable and Locally Advanced Unresectable Pancreatic Cancer: A Single-Center, Retrospective Analysis
por: Yoo, Changhoon, et al.
Publicado: (2019) -
Neoadjuvant Chemotherapy with Capecitabine and Temozolomide for Unresectable Pancreatic Neuroendocrine Tumor
por: Devata, Sumana, et al.
Publicado: (2012) -
Concurrent Chemotherapy and Pulsed High-Intensity Focused Ultrasound Therapy for the Treatment of Unresectable Pancreatic Cancer: Initial Experiences
por: Lee, Jae Young, et al.
Publicado: (2011) -
Efficacy of Chemotherapy in Patients with Unresectable or Metastatic Pancreatic Acinar Cell Carcinoma: Potentially Improved Efficacy with Oxaliplatin-Containing Regimen
por: Yoo, Changhoon, et al.
Publicado: (2017)